Literature DB >> 10090820

Evaluation of a hybrid artificial liver using a polyurethane foam packed-Bed culture system in dogs.

T Gion1, M Shimada, K Shirabe, K Nakazawa, H Ijima, T Matsushita, K Funatsu, K Sugimachi.   

Abstract

BACKGROUND AND AIMS: We developed a polyurethane foam packed-bed culture system of hepatocyte spheroids as a hybrid artificial liver (PUF-HAL), which was effective for recovery from liver failure in rat experiments. In this report, the design of a scaled-up PUF-HAL for dogs is described and evaluated using a dog acute liver failure model.
METHODS: Warm ischemic liver failure was induced with a portocaval shunt in each dog. The dogs were divided into two groups: (1) a control group (N = 4), in which each dog was attached to a PUF-HAL without hepatocytes for 9 h, and (2) a HAL group (N = 5), in which each dog was attached to a PUF-HAL with hepatocytes. Blood pressure, blood ammonia, blood glucose, serum creatinine, and other parameters related to liver function were compared between the two groups.
RESULTS: In the HAL group, blood ammonia and serum creatinine levels were significantly lower, and blood pressure and blood glucose levels significantly higher, than those in the control group.
CONCLUSIONS: The scaled-up PUF-HAL developed for large animals is useful as a liver support system in the dog acute liver failure model. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090820     DOI: 10.1006/jsre.1998.5540

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Microgravity as a means to incorporate HepG2 aggregates in polysaccharide-protein hybrid scaffold.

Authors:  P R Sarika; Nirmala Rachel James; P R Anilkumar; Deepa K Raj; T V Kumary
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

2.  The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.

Authors:  Mei Niu; Paul Hammond; Robin N Coger
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.